Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kapanol once daily versus MS Contin twice daily for moderate to severe cancer pain
CTR20244778Phase 3Completed
- Sponsor
- Mayne Pharma
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of morphine hydrochloride in cancer pain, sponsored by Mayne Pharma. Started Mar 2025; status: completed.
02
Drugs
morphine hydrochloride
03
Conditions
cancer pain
Beyond the preview
Go deeper on CTR20244778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244778.